What You Should Know:
– Color Health, a provider of precision health solutions released its second annual Employer Insights Report, revealing a disconnect between employer priorities and the reality of cancer care benefits offered to…
Continue Reading
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
What You Should Know:
– Nucs AI, a company that uses AI in precision medicine for the diagnosis and treatment of prostate cancer, today announces that it has closed a $3.5 million seed round of…
Continue Reading
Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a company that offers AI-powered software to help providers better understand cancer risk, announced they are joining forces to develop…
Continue Reading
Introduction
The Transpara Breast AI system is transforming breast cancer screening by delivering unmatched diagnostic precision and reducing false negatives. Developed with cutting-edge artificial intelligence, Transpara assists radiologists in detecting cancers that might otherwise go…
Esophageal cancer is one of the most deadly cancers — so why doesn’t the healthcare industry have better tools to prevent the disease?
Lucid Diagnostics is on a mission to solve that problem. The company…
Continue Reading
Advancing precision in lung cancer diagnostics: Lunit’s collaboration with AstraZeneca aims to transform the speed and accuracy of detecting actionable mutations in NSCLC. (Courtesy of Lunit)
What You Should Know:
– Lunit, a provider of AI…
Continue Reading
What You Should Know:
– Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
– The partnership will expand…
Continue Reading
